Evidence map›Paper›PMID 36465269›Full record

ReviewInternational journal of general medicine2022

Traditional Chinese Medicine in Treatment of COVID-19 and Viral Disease: Efficacies and Clinical Evidence.

Xue Ding, Lei-Lei Fan, Shi-Xi Zhang, Xiu-Xia Ma, Peng-Fei Meng, Liang-Ping Li, Ming-Yan Huang, Jia-Le Guo, Peng-Zhan Zhong, Li-Ran Xu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xue DingDepartment of Medical, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Lei-Lei FanDepartment of Cardiovascular, Yellow River Central Hospital, Zhengzhou, People's Republic of China.
Shi-Xi ZhangDepartment of Infectious Disease, Shangqiu Municipal Hospital, Shangqiu, People's Republic of China.
Xiu-Xia MaDepartment of AIDS Clinical Research Center, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Peng-Fei MengDepartment of AIDS Clinical Research Center, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Liang-Ping LiDepartment of the First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Ming-Yan HuangDepartment of the First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Jia-Le GuoDepartment of the First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Peng-Zhan ZhongDepartment of the First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Li-Ran XuDepartment of the First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.ORCID 0000-0002-3992-7423
First Affiliated Hospital of Henan University · CNShangqiu First People's Hospital · CNYellow River Institute of Hydraulic Research · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) remains an uncontained, worldwide pandemic. While battling the disease in China, the Chinese government has actively promoted the use of traditional Chinese medicine, and many studies have been conducted to determine the efficacy of traditional Chinese medicine for treating COVID-19. The present review discusses the effectiveness and safety of traditional Chinese medicine in curing COVID-19 and provides clinical evidence from all confirmed cases in China. Applications of traditional Chinese medicine and specific recipes for treating other viral infections, such as those caused by severe acute respiratory syndrome coronavirus and influenza A viruses (including H1N1), are also discussed. Studies have reported that traditional Chinese medicine treatment plays a significant role in improving clinical symptoms. Therefore, further investigation may be of high translational value in revealing novel targeted therapies for COVID-19.

Indexed as

acute respiratory syndrome coronavirusclinical evidencecoronavirus disease-2019influenza A virusestraditional Chinese medicine

Identifiers

PMID36465269
PMCPMC9718497
OpenAlexW4310249246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.